Japan Expands Priority R&D List For Regular Vaccinations

MMRV, Norovirus Included

Japan adds four new pediatric vaccines, including for MMRV and norovirus, to a list of priority vaccines eligible for assistance in regulatory processing.

Japan's priority vaccine R&D list
Japan listed four pediatric indications as a priority in its vaccine R&D strategy. (Shutterstock)

Japan has renewed and expanded its list of priority regular vaccinations for public health, adding four pediatric indications to those for which it will provide policy support for vaccine development.

The 13 March revised list includes a six-in-one vaccine for pertussis, diphtheria, tetanus, polio, Haemophilus influenzae type b (Hib) and hepatitis B, and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Japan

More from R&D